Details for United Kingdom Supplementary Protection Certificate: SPC/GB07/058
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1104436 | SPC/GB07/058 | United Kingdom | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB07/058 GRANTED TO NOVARTIS AG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE AND L UNIVERSITE MONTPELLIER II IN RESPECT OF THE PRODUCT TELBIVUDINE AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6311 DATED 05 MAY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 25 APRIL 2022. | ⤷ Start Trial |
